Adaptive Biotechnologies Corporation is a biotechnology business based in the US. Adaptive Biotechnologies Corporation stocks (ADPT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $28.33 – a decrease of 11.85% over the previous week. Adaptive Biotechnologies Corporation employs 622 staff and has a trailing 12-month revenue of around $146.6 million.
How to buy shares in Adaptive Biotechnologies Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ADPT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Adaptive Biotechnologies Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Adaptive Biotechnologies Corporation?
- Has coronavirus impacted Adaptive Biotechnologies Corporation shares?
- Adaptive Biotechnologies Corporation shares summary
- Compare share dealing platforms
- Is Adaptive Biotechnologies Corporation stock a buy or sell?
- Adaptive Biotechnologies Corporation performance over time
- Adaptive Biotechnologies Corporation's financials
- How volatile are Adaptive Biotechnologies Corporation shares?
- Does Adaptive Biotechnologies Corporation pay a dividend?
- Other common questions
How has Coronavirus impacted Adaptive Biotechnologies Corporation's stock price?
Since the stock market crash in March caused by coronavirus, Adaptive Biotechnologies Corporation's stock price has had significant negative movement.
Its last market close was $19.35, which is 43.35% down on its pre-crash value of $34.16 and 27.39% up on the lowest point reached during the March crash when the stocks fell as low as $15.19.
If you had bought $1,000 worth of Adaptive Biotechnologies Corporation stocks at the start of February 2020, those stocks would have been worth $755.26 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $644.94.
Adaptive Biotechnologies Corporation stock price (NASDAQ:ADPT)Use our graph to track the performance of ADPT stocks over time.
Adaptive Biotechnologies Corporation shares at a glance
|Latest market close||$19.35|
|52-week range||$18.74 - $71.25|
|50-day moving average||$27.83|
|200-day moving average||$34.58|
|Wall St. target price||$52.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.37|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Adaptive Biotechnologies Corporation price performance over time
|1 week (2022-01-10)||-11.85%|
|1 month (2021-12-16)||-26.37%|
|3 months (2021-10-13)||-41.45%|
|6 months (2021-07-17)||-48.93%|
|1 year (2021-01-15)||-70.27%|
|2 years (2020-01-17)||-31.41%|
|3 years (2019-01-13)||N/A|
|5 years (2017-01-13)||N/A|
Adaptive Biotechnologies Corporation financials
|Revenue TTM||$146.6 million|
|Gross profit TTM||$-40,220,000|
|Return on assets TTM||-11.47%|
|Return on equity TTM||-26.71%|
|Market capitalisation||$2.7 billion|
TTM: trailing 12 months
Adaptive Biotechnologies Corporation share dividends
We're not expecting Adaptive Biotechnologies Corporation to pay a dividend over the next 12 months.
Adaptive Biotechnologies Corporation share price volatility
Over the last 12 months, Adaptive Biotechnologies Corporation's shares have ranged in value from as little as $18.74 up to $71.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adaptive Biotechnologies Corporation's is 0.3748. This would suggest that Adaptive Biotechnologies Corporation's shares are less volatile than average (for this exchange).
Adaptive Biotechnologies Corporation overview
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery customers. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test.
Frequently asked questions
Adaptive Biotechnologies Corporation in the news
Adaptive Biotechnologies Corp Shares Fall 6.2% Below Previous 52-Week Low - Market Mover
Adaptive Biotechnologies is Now Oversold (ADPT)
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
The ChampCoin (TCC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.